5 hours Ago
Suspense crime, Digital Desk : Becase of the terrorist attack in Pahalgam, India is thinking about restricting medicine exports to Pakistan as part of broader economic reprisals against the country. This move is aimed at straining the economy of Islamabad as the two countries escalate their hostile relations. News18 reports that India’s Department of Pharmaceuticals set a deadline on Pharmexcil for providing export data on medicines and allied products for Pakistan exports.
Export as well as Import Analysis Between India and Pakistan Out of 219 countries that India exports to, Pakistan stands at 38th position in terms of pharmaceutical exports. For the fiscal year 2024, it was reported that India exported pharmaceutical products worth 176.54 million USD to Pakistan.
New reports claim that this figure has now increased to about 200 million dollars. This figure underlines the level of dependence which Pakistan has on Indian supplies for Pharmaceutical products and essential medicines. Dubai: The Main Regional Center A source acquainted with the matter told News 18 that a significant portion of India's Pharmaceutical trade with Pakistan is transited through Dubai.
Dubai serves as a major center for the importation of Indian goods which include medicines and other pharmaceutical products into Pakistan. Consequences of Possible Limitation on Export Trade Pakistan is mainly supplied with pharma exports from India that include APIs or bulk drugs. If India goes through with the restrictions, it will have no affect on India’s domestic market but could severely impact Pakistan’s access to affordable APIs.
Pakistan may have to reroute its imports which will increase the costs and delays. The needed pharmaceutical raw materials will have to come from different suppliers which will put an additional strain financially on Pakistan’s already burdened economy. Read More: India Considers Airspace Ban on Pakistan Amid Rising Diplomatic Tensions.
